Vertex’s CRISPR gene therapy lands another FDA nod

The latest stories trending on MedCity News.

Editor's Pick

Top Story Vertex's CRISPR Gene Therapy Lands Another FDA Nod in a Rare Blood Disease The FDA approved Vertex Pharmaceuticals' gene therapy Casgevy for treating beta thalassemia, an inherited blood disease that leads to low levels of functioning hemoglobin. Last month, the one-time treatment won its first FDA nod for treating sickle cell disease. Sponsored Content Improving Patient Experience Through Informed Decision-Making Presented by Care Logistics Informed decision-making is crucial to operational efficiency, which fundamentally impacts the patient experience, but how do you facilitate it?    Learn more here. What's the ROI for Attending INVEST 2024? Convenience, budget friendly (less than a latte a day), and the biggest benefit/ROI is networking. A 2023 attendee said, "I was impressed by the mix of attendees and intentionality behind the networking sessions." It doesn't get any better, this is the best of the best when it comes to networking in healthcare. Register Today and Save!

Featured News

5 Ways Google Is Protecting Kids' Mental Health on YouTube During a session at CES 2024, a Google exec shared several changes the company has made through YouTube to protect children and teens. Boulder Care Extends Virtual Substance Use Disorder Treatment to Adolescents As the opioid crisis grows for teens, Boulder Care has expanded its substance use disorder treatment to support adolescents. The company is starting its adolescent services in Washington with UnitedHealthcare Community Plan. Innovaccer Acquires Cured to Enhance Its Patient Engagement Strategy Innovaccer acquired Cured, a healthcare digital marketing and CRM platform. With the deal, Innovaccer gains more than 20 customers to add to its current portfolio of clients. Innovaccer CEO Abhinav Shashank said the main goal of the acquisition was to help his company become a leader in patient experience technology. More Than a Survey: How to Holistically Embrace the Patient Experience Despite the challenges that healthcare providers face and declining patient experience scores, several effective strategies can enhance their work to improve the patient experience and sufficiently satisfy expectations for care. Allakos Skin Drug Fails 2 Mid-Stage Tests, Sparks Restructuring to Cut 50% of Staff Allakos's lirentelimab did not beat a placebo in separate Phase 2 tests in atopic dermatitis and spontaneous chronic urticaria. A restructuring now turns the biotech's focus to an early-stage drug candidate also designed to treat inflammation.

Resources

Free eBook: "AI in Healthcare: Scratching the Surface" Learn how AI is transforming the healthcare industry and the pitfalls that also exist with its early adoption. Download Now

MedCity News • PO Box 901 • New York, NY unsubscribe